High materiality7/10
Starling Oncology price target raised to $9 from $7 at Needham
Why it may matterVerify against the original reporting
Bullish setup: upside implied as target exceeds current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Needham raises Starling Oncology's target to $9; current price is $6.70.
- Target $9; Price $6.70; Firm: Needham
Key facts
- 01
Target: $9
- 02
Posted price: $6.7
- 03
Analyst firm: Needham
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.